When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
2019 has been a busy year for Foamix Pharmaceuticals (FOMX) but the second half of this year will be even busier with several major events. The company has a PDUFA date on October 20 for its most advanced candidate FMX101 for acne. If approved, FMX101 would be the company’s first commercial product and is expected to launch at the beginning of 2020. Foamix also has plans to file another NDA for FMX103 in papulopustular rosacea at some point in the coming weeks. As a result, the company is working on pre-launch activities for